Clin2
NCT07792122Possibly a fitNot yet recruiting

Propranolol for post-traumatic stress in women after violence

Post-Traumatic Stress Disorder, PTSD

Treatments studied

Part of Mental health clinical trials.

This study tests whether a medicine called propranolol can help women who have experienced severe violence and now have post-traumatic stress disorder (PTSD). It aims to reduce symptoms by reactivating traumatic memories while taking the medicine.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
70 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 75 years old.
  • You have experienced severe violence such as rape, sexual assault, or physical assault.
  • You currently have PTSD, diagnosed by a professional, with a recent score of at least 33 on a PTSD assessment scale.
  • Your resting heart rate is at least 55 beats per minute.
  • You are not currently taking beta-blockers or certain psychiatric medications, or you can safely stop them for at least 2 weeks (6 weeks if fluoxetine).
  • You are willing to use contraception if you could become pregnant, and you are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07644338Recruiting
Brain Stimulation for Post-Traumatic Stress Disorder

This study tests a new non-invasive brain stimulation technique called temporal interference stimulation to help reduce PTSD symptoms. If you have PTSD that's lasted at least 3 months, this trial may help you or contribute to better treatments for others.

Shanghai
NCT04985344Recruiting· Phase 3
Propranolol to treat PTSD symptoms in children using memory reactivation

This trial studies whether propranolol (a heart-related medicine) can help children with post-traumatic stress disorder (PTSD) after a special memory-activation session. The goal is to reduce PTSD symptoms compared with the comparison condition.

Toulouse
NCT07452978Not yet recruiting· Phase 2
Propranolol to prevent post-traumatic stress disorder after sexual violence

This trial tests a medicine called propranolol (a beta-blocker, usually used for heart conditions) to see if taking it soon after a sexual assault can help prevent the development of PTSD. It is for women who come to a medical-legal unit within 72 hours of the assault.

NCT05853627Recruiting· Phase 4
Propranolol versus standard therapy for trauma imagery reactions

This study tests whether propranolol (a beta-blocker) changed alongside a standard approach can reduce how strongly your body reacts during traumatic imagery. It’s meant for adults who have had a traumatic event and may help lessen fear and stress responses tied to those memories.

Charlestown, Massachusetts
NCT07485231Recruiting
Nitric oxide and blood vessel function in women with PTSD

This study tests how well blood vessels work in women with PTSD by measuring nitric oxide levels. It may help understand why PTSD affects heart health and could lead to better treatments.

Minneapolis, Minnesota
NCT02560805Recruiting· Phase 2
Study drugs that affect stress nerves and blood pressure in PTSD

This Phase 2 study looks at how stress-related nerve activity and a hormone called angiotensin II may be involved in PTSD, and how specific blood-pressure-related medicines affect the body. You may be eligible if you are a PTSD patient (or a matched control without PTSD) and meet safety criteria.

Decatur, Georgia

Hear when a new Post-Traumatic Stress Disorder, PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.